S. Chichareon et al., RISK-FACTORS FOR CERVICAL-CANCER IN THAILAND - A CASE-CONTROL STUDY, Journal of the National Cancer Institute, 90(1), 1998, pp. 50-57
Background: Human papillomaviruses (HPV) types 16 and 18 are clearly i
nvolved in the etiology of cervical cancer, but the evidence for the c
arcinogenicity of other HPV types is limited, Cofactors involved in th
e progression from infection with HPV to high-grade precursors and can
cer have not been clearly defined by the results of previous studies,
Methods: We conducted a hospital-based, case-control study of invasive
cervical cancer to investigate risk in relation to HPV infection and
its epidemiologic cofactors in Hat-Yai, Thailand, A total of 338 patie
nts with squamous cell carcinoma, 39 patients with adenocarcinoma/aden
osquamous carcinoma, and 261 control subjects were included in the stu
dy and were interviewed to obtain information with regard to cervical
cancer risk factors, HPV DNA presence in cervical exfoliated cells or
frozen biopsy specimens was determined by a polymerase chain reaction
assay, Results: HPV DNA was detected in 95% of patients with squamous
cell carcinoma, 90% of those with adenocarcinoma/adenosquamous carcino
ma, and 16% of control subjects, For patients with squamous cell carci
noma, the most common types of HPV found were type 16 (60% of the posi
tives), type 18 (18%), type 58 (3%), type 52 (3%), and type 31 (2%), F
or patients with adenocarcinoma/adenosquamous carcinoma, the most comm
on HPV types found were type 18 (60% of the positives), type 16 (37%),
and type 45 (3%), The risk factors that remained associated with risk
of both histologic types after adjustment for HPV and their mutual co
nfounding effects were limited education, increasing number of sexual
partners, history of venereal diseases, and interval since last Pap sm
ear (i.e., cytologic) test, Among patients with squamous cell carcinom
a, some association with smoking was also observed, Conclusion: New pr
eventive strategies for cervical cancer will require the consideration
of multiple HPV types.